Skip to content
Evigrade
MinorOther dermatologicals (topical); peripheral vasodilators (systemic)×Bile acid preparations

Updated · Methodology

Mechanism

Ursodeoxycholic acid is absorbed in the small intestine, conjugated with glycine or taurine in the liver and secreted into bile. Apart from this conjugation and a small bacterial conversion in the gut, it is not metabolised (ursodeoxycholic acid SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). In the liver, minoxidil is mainly conjugated with glucuronic acid, and minoxidil and its metabolites are excreted in the urine (minoxidil SmPCs, AEMPS). Between 1% and 2% of a dose of scalp foam or solution reaches the circulation (minoxidil scalp foam SmPC, AEMPS). According to its SmPC, ursodeoxycholic acid could in theory affect the absorption of other lipophilic substances. The minoxidil documents do not describe minoxidil as lipophilic, and at least 90% of an oral minoxidil dose is absorbed (ursodeoxycholic acid and minoxidil SmPCs, AEMPS). No document names the pair.

Symptoms

The documents describe no symptoms of this combination. A common adverse effect of ursodeoxycholic acid is pasty stools or diarrhoea (ursodeoxycholic acid SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS), and the US label lists alopecia among its most common adverse reactions (URSO label, US Food and Drug Administration, FDA). Minoxidil on the scalp commonly causes itching, dermatitis, rash, headache and unwanted hair growth outside the scalp (minoxidil scalp foam SmPC, AEMPS). Minoxidil tablets cause salt and water retention, oedema and, in most people, increased body hair (minoxidil tablets SmPC, AEMPS).

Management

According to the documents, the combination is acceptable, and the doses of ursodeoxycholic acid and minoxidil need no change. No document names the pair (ursodeoxycholic acid SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, and URSO label, US Food and Drug Administration, FDA; minoxidil SmPCs, AEMPS, and minoxidil tablets label, FDA). Ursodeoxycholic acid is used, among other indications, for primary biliary cholangitis. During the first 3 months of treatment, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) are checked every 4 weeks, and every 3 months after that (ursodeoxycholic acid SmPCs, AEMPS). If minoxidil is taken by mouth in hepatic impairment, consider whether the dose needs adjusting: start with a reduced dose once daily and increase it gradually to the lowest effective dose (minoxidil tablets SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Minoxidil

Other interactions with Ursodeoxycholic acid